Alvin Mach

Alvin Mach currently serves as Manager of Commercial Operations at Axsome Therapeutics, Inc., focusing on the success of commercial CNS products Auvelity and Sunosi through pharmaceutical sales operations, data analytics, and incentive compensation strategy. Previously, Alvin was a Consultant at PA Consulting, providing strategic advice on growth and operating models. Experience includes a role as Credit Derivatives Analyst at Scotiabank, where support was given to hedge fund clients with substantial portfolios, and as Operations Associate at Brigham and Women's Hospital, overseeing lab operations. Alvin also contributed to research as a Research Fellow at Boston College, specializing in systems biology. Educational qualifications comprise a Bachelor of Science in Biology from Boston College and a Master of Science in Biotechnology from Northeastern University.